rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Oxygenta Pharmaceutical Ltd. - Research Center
524636 OXYGENTAPH Group (XT) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18
Sources of funds
Owner's fund
Equity share capital 14.20 10.20 10.20 10.20 10.20
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus -48.83 -48.22 -51.15 -45.36 -42.11
Loan funds
Secured loans 52.13 2.85 1.00 0.99 1.76
Unsecured loans - 45.04 24.94 20.37 16.26
Total 17.50 9.87 -15.01 -13.80 -13.89
Uses of funds
Fixed assets
Gross block 20.32 31.18 25.10 24.58 23.99
Less : revaluation reserve - - - - -
Less : accumulated depreciation - 14.87 13.68 12.68 11.70
Net block 20.32 16.31 11.42 11.90 12.29
Capital work-in-progress - 0.65 - - 0.06
Investments 0.05 0.05 0.05 0.05 0.05
Net current assets
Current assets, loans & advances 10.81 16.85 7.15 9.21 4.57
Less : current liabilities & provisions 13.68 24.00 33.63 34.96 30.85
Total net current assets -2.87 -7.15 -26.48 -25.75 -26.29
Miscellaneous expenses not written - - - - -
Total 17.50 9.87 -15.01 -13.80 -13.89
Notes:
Book value of unquoted investments - - - - -
Market value of quoted investments - - - - -
Contingent liabilities - 1.20 1.20 1.20 1.20
Number of equity sharesoutstanding (Lacs) 142.01 102.01 102.01 102.01 102.01

Mutual Fund Selector

Find the fund that is right for you
Close
Add Oxygenta Pharmaceutical Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Oxygenta Pharmaceutical Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close